- cross-posted to:
- [email protected]
- [email protected]
- [email protected]
- cross-posted to:
- [email protected]
- [email protected]
- [email protected]
cross-posted from: https://mander.xyz/post/11304633
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Those are the costs of doing business, and can be greatly exaggerated. And other counties produce profitable drugs even with price restrictions. We’re so accustomed to price gouging, that we don’t recognize it.